SEC Form 4 · accession 0001140361-16-053822
Protea Biosciences Group, Inc. · PRGB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Patrick Joseph Gallagher
Director
Period of report
Dec 18, 2015
Accepted (ET)
Feb 17, 2016 · 9:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001335103
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 18, 2015 | A | 80,000 | $0.00 | A | 80,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Director Stock Option (right to buy)F1 | $0.25 | Dec 18, 2015 | A | 66,667 | A | Dec 1, 2016 | Dec 1, 2025 | Common Stock | 66,667 | 66,667 | D |
Explanation of responses
- F1The option vests 100% on December 1, 2016.